Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2017-10-17
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Versus Late Interval Postpartum Copper Intrauterine Device Insertion
NCT03106805
Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality
NCT01805817
Shifting of Intrauterine Device and Use of the Menstrual Cup: Case-control Study
NCT04782583
A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).
NCT02957292
The Copper T380A IUD vs. Oral Levonorgestrel for Emergency Contraception
NCT00966771
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. The Research Hypothesis: (Null hypothesis)
• In women using copper IUD, discontinuation rate in primary health care unit and university clinic may be similar.
2. The Research Question:
• In women using copper IUD, Does discontinuation rate in primary health care unit and university clinic differ?
3. METHODOLOGY:
Patients and Methods
• Study setting:
* Family planning Outpatient clinic of Ain Shams Maternity Hospital, (ASUMH)
* primary health care unit in ain shams area
• Study population:
* Study period: 1 year
* Sample size: was calculated using Sample size computer program 11. After review of literature, no previous similar study was done before, so assume a discontinuation rate of 50% among Cu-IUD users in primary healthcare unit and 25% among Cu-IUD users in university clinic. Based on these values; the study will include 170 Cu-IUD users; equally selected as 85 subjects from each clinic. But due to the expected drop outs, recruitment will start by 200 women from each clinic.
* Statistics:
* Descriptive statistics for measured variables will be expressed as range, mean and standard deviation (for metric data); range, median and interquartile range (for discrete data); and number and proportions (for categorical data). Cu-IUD discontinuation findings in each clinic will be compared using the t-test or the Mann-whitney U test depending on whether the measured parameters are guassian variables. A P-value of 0.05 or less will be considered statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
university clinic
* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion
* Informed Consent: All participants will give their informed consent prior to enrollment.
* Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF).
* Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.
Cu-IUD
Copper Intra-uterine device used as contraceptive method
primary healthcare unit clinic
* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion
* Informed Consent: All participants will give their informed consent prior to enrollment.
* Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF).
* Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.
Cu-IUD
Copper Intra-uterine device used as contraceptive method
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cu-IUD
Copper Intra-uterine device used as contraceptive method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
49 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
noha mohamed elzaydy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
noha mohamed elzaydy
researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ain Shams Maternity Hospital
Role: STUDY_DIRECTOR
Ain Shams Maternity Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Maternity hospital
Cairo, Ain Shams, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cu-IUD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.